miR-152 functions as a tumor suppressor in colorectal cancer by targeting PIK3R3

Area of Science:

• Oncology
• Molecular Biology
• Genetics

Background:

• MicroRNA-152 (miR-152) is recognized as a tumor suppressor in various cancers.
• Its specific role and regulatory mechanisms in colorectal cancer (CRC) remain largely unelucidated.
• Understanding miR-152's function is crucial for developing novel CRC therapies.

Purpose of the Study:

• To investigate the biological role of miR-152 in colorectal cancer (CRC).
• To identify the molecular mechanisms underlying miR-152's function in CRC.
• To explore the potential of miR-152 as a therapeutic target in CRC.

Main Methods:

• Quantitative real-time PCR to assess miR-152 expression in CRC cell lines and tissues.
• In vitro functional assays (proliferation, migration, invasion, apoptosis, caspase-3 activity) to evaluate miR-152's effects.
• In vivo tumor growth assays in mouse models.
• Bioinformatic analysis and luciferase reporter assays to identify and validate miR-152 targets.
• Western blotting to confirm protein expression levels.

Main Results:

• miR-152 expression was significantly downregulated in CRC cell lines and tissues, correlating inversely with advanced TNM stage and lymph node metastasis.
• Overexpression of miR-152 suppressed CRC cell proliferation, migration, and invasion, while promoting apoptosis and caspase-3 activity in vitro and inhibiting tumor growth in vivo.
• Phosphoinositide-3-kinase regulatory subunit 3 (PIK3R3) was identified as a direct downstream target of miR-152.
• PIK3R3 expression was upregulated in CRC tissues and inversely correlated with miR-152 levels. Silencing PIK3R3 mimicked the tumor-suppressive effects of miR-152.

Conclusions:

• miR-152 functions as a tumor suppressor in colorectal cancer (CRC).
• miR-152 exerts its tumor-suppressive effects by directly targeting and downregulating PIK3R3 expression.
• miR-152 represents a potential therapeutic biomarker and target for colorectal cancer treatment.